Cargando…

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

Detalles Bibliográficos
Autores principales: Asano, Aya, Ueda, Shigeto, Kuji, Ichiei, Yamane, Tomohiko, Takeuchi, Hideki, Hirokawa, Eiko, Sugitani, Ikuko, Shimada, Hiroko, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123998/
https://www.ncbi.nlm.nih.gov/pubmed/30185224
http://dx.doi.org/10.1186/s13058-018-1038-3
_version_ 1783352948121665536
author Asano, Aya
Ueda, Shigeto
Kuji, Ichiei
Yamane, Tomohiko
Takeuchi, Hideki
Hirokawa, Eiko
Sugitani, Ikuko
Shimada, Hiroko
Hasebe, Takahiro
Osaki, Akihiko
Saeki, Toshiaki
author_facet Asano, Aya
Ueda, Shigeto
Kuji, Ichiei
Yamane, Tomohiko
Takeuchi, Hideki
Hirokawa, Eiko
Sugitani, Ikuko
Shimada, Hiroko
Hasebe, Takahiro
Osaki, Akihiko
Saeki, Toshiaki
author_sort Asano, Aya
collection PubMed
description
format Online
Article
Text
id pubmed-6123998
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61239982018-09-10 Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693) Asano, Aya Ueda, Shigeto Kuji, Ichiei Yamane, Tomohiko Takeuchi, Hideki Hirokawa, Eiko Sugitani, Ikuko Shimada, Hiroko Hasebe, Takahiro Osaki, Akihiko Saeki, Toshiaki Breast Cancer Res Correction BioMed Central 2018-09-05 2018 /pmc/articles/PMC6123998/ /pubmed/30185224 http://dx.doi.org/10.1186/s13058-018-1038-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Asano, Aya
Ueda, Shigeto
Kuji, Ichiei
Yamane, Tomohiko
Takeuchi, Hideki
Hirokawa, Eiko
Sugitani, Ikuko
Shimada, Hiroko
Hasebe, Takahiro
Osaki, Akihiko
Saeki, Toshiaki
Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title_full Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title_fullStr Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title_full_unstemmed Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title_short Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
title_sort correction to: intracellular hypoxia measured by f-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (brcr-d17-00693)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123998/
https://www.ncbi.nlm.nih.gov/pubmed/30185224
http://dx.doi.org/10.1186/s13058-018-1038-3
work_keys_str_mv AT asanoaya correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT uedashigeto correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT kujiichiei correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT yamanetomohiko correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT takeuchihideki correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT hirokawaeiko correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT sugitaniikuko correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT shimadahiroko correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT hasebetakahiro correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT osakiakihiko correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693
AT saekitoshiaki correctiontointracellularhypoxiameasuredbyf18fluoromisonidazolepositronemissiontomographyhasprognosticimpactinpatientswithestrogenreceptorpositivebreastbrcrd1700693